Glimepiride Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
Conditions:   Coronary Artery Disease;   Diabetes Mellitus, Type 2 Interventions:   Drug: Vildagliptin 50 mg Oral Tablet;   Drug: Metformin 1000 mg Oral Tablet;   Drug: Glimepiride 4 mg Oral Tablet Sponsor:   Damanhour University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2018 Category: Research Source Type: clinical trials

Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
Conditions:   Coronary Artery Disease;   Diabetes Mellitus, Type 2 Interventions:   Drug: Vildagliptin 50 mg Oral Tablet;   Drug: Metformin 1000 mg Oral Tablet;   Drug: Glimepiride 4 mg Oral Tablet Sponsor:   Damanhour University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2018 Category: Research Source Type: clinical trials